← Browse by Condition
Medical Condition

open angle glaucoma

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for open angle glaucoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — open angle glaucoma Clinical Trials

How many clinical trials are currently recruiting for open angle glaucoma?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for open angle glaucoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for open angle glaucoma?
open angle glaucoma research spans Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a open angle glaucoma clinical trial?
Eligibility criteria for open angle glaucoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
2
Top Sponsors
iSTAR Medical 2 trials
Prairie Eye Center 1 trial
University of Miami 1 trial
Barnet Dulaney Perkins Eye Centers 1 trial

Recruiting Clinical Trials

NCT06883123 Phase 4
Recruiting

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

Enrollment
70 pts
Location
United States
Sponsor
Prairie Eye Center
View Trial →
NCT05269680
Recruiting

STAR-LIFE: a Post-market Registry on MINIject

Enrollment
750 pts
Location
Switzerland
Sponsor
iSTAR Medical
View Trial →
NCT04524416
Recruiting

MINIject Global Long-Term Follow-up Study

Enrollment
300 pts
Location
Colombia, France, Ge...
Sponsor
iSTAR Medical
View Trial →
NCT07217678 Phase 4
Recruiting

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

Enrollment
20 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT06953349
Recruiting

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Enrollment
300 pts
Location
United States
Sponsor
Barnet Dulaney Perkins Eye Cen...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology